Ebola Survivor Blood Trials May Pave Way for Use Early Next Year

Blood taken from Ebola survivors may be used to treat those infected with the deadly virus early next year, before vaccines or experimental drugs become available, according to the World Health Organization.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.